Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Rheumatic Heart Disease
94%
Indonesia
87%
Congenital Heart Disease
72%
Right-to-left Shunt
68%
Transcatheter Closure
63%
Oxygen Saturation
63%
Pulmonary Arterial Hypertension
44%
Echocardiography
43%
Indonesian
37%
Environmental Factors
36%
Confidence Interval
34%
Clinical Profile
31%
Cupping Therapy
31%
Length Parameter
31%
Drug Groups
31%
Right Ventricular Fibrosis
31%
Kawasaki Disease
31%
Coronary Artery Dilatation
31%
HLA-DRB1 Alleles
31%
Allele Distribution
31%
Pulmonary Artery Hypertension
31%
Cyanotic Congenital Heart Disease
31%
Acute Lymhoblastic Leukemia
31%
Childhood Acute Lymphoblastic Leukemia
31%
Subaortic Stenosis
31%
Multifunctional Occluder
31%
Mid-term Outcome
31%
Cardiotoxicity
31%
Perimembranous Ventricular Septal Defect
31%
Lifetech
31%
Pulmonary Hypertension
31%
Konar
31%
Beraprost Sodium
31%
QT Interval
31%
Pharmacological Therapy
31%
Type I Collagen
31%
Medan
31%
Pomegranate Peel Extract
31%
Septic Shock
31%
Risk Factors
31%
Low-density Lipoprotein
31%
Serum Electrolyte Levels
31%
Matrix metalloproteinase-1 (MMP-1)
31%
Tissue Inhibitor of metalloproteinase-1 (TIMP-1)
31%
High-density Lipoprotein Cholesterol (HDL-C)
31%
Early Indicators
31%
Heart Failure Treatment
31%
Duration of Illness
31%
Type 1 Diabetes Mellitus (T1DM)
31%
Dilatation
31%
Medicine and Dentistry
Persistent Truncus Arteriosus
100%
Rheumatic Heart Disease
94%
Pulmonary Hypertension
81%
Heart Left Right Shunt
69%
Ventricular Septal Defect
63%
Congestive Heart Failure
55%
Echocardiography
48%
Diseases
42%
Environmental Factor
36%
Tricuspid Insufficiency
32%
QT Dispersion
31%
Coronary Artery Dilatation
31%
Kawasaki Disease
31%
HLA-DRB1
31%
Beraprost
31%
Subvalvular Aortic Stenosis
31%
Allele
31%
Collagen Type 1
31%
Heart Left Ventricle Failure
31%
Pomegranate Extract
31%
Fibrosis
31%
Septic Shock
31%
ACE Inhibitor
31%
Interstitial Collagenase
31%
Tissue Inhibitor of Metalloproteinase 1
31%
Insulin Dependent Diabetes Mellitus
31%
Metabolic Regulation
31%
Angiotensin Receptor Antagonist
31%
Oxygen Saturation
31%
Retrospective Study
31%
Liposomal Daunorubicin
31%
Acute Lymphoblastic Leukemia
31%
Leukemia
31%
Cardiotoxicity
31%
Scoring System
31%
Iron Overload
31%
Thalassemia
31%
Pulmonary Atresia
31%
Reticulocyte
22%
Pediatrics
20%
Anthracycline
18%
Hemoglobins
18%
Heart Left Ventricle Ejection Fraction
17%
near Infrared Spectroscopy
15%
Rheumatic Fever
13%
Electrocardiography
13%
High Risk Population
12%
Odds Ratio
12%
Hemoglobin A1c
11%
Electrocardiogram
11%
Pharmacology, Toxicology and Pharmaceutical Science
Congenital Heart Disease
68%
Heart Left Right Shunt
68%
Rheumatic Heart Disease
63%
Pulmonary Hypertension
49%
Congestive Heart Failure
47%
Diseases
42%
Tissue Inhibitor of Metalloproteinase 1
31%
Collagen Type 1
31%
Dipeptidyl Carboxypeptidase Inhibitor
31%
Fibrosis
31%
Angiotensin Receptor Antagonist
31%
Pomegranate Extract
31%
HLA DRB1 Antigen
31%
Subvalvular Aortic Stenosis
31%
Beraprost
31%
Cupping Therapy
31%
Heart Ventricle Septum Defect
31%
Low Density Lipoprotein
31%
Interstitial Collagenase
31%
High Density Lipoprotein
31%
Insulin Dependent Diabetes Mellitus
31%
Heart Left Ventricle Failure
31%
Retrospective Study
31%
Leukemia
31%
Acute Lymphoblastic Leukemia
31%
Cardiotoxicity
31%
Daunorubicin
31%
Low Density Lipoprotein Cholesterol
23%
Anthracycline
18%
High Density Lipoprotein Cholesterol
15%
Hemoglobin A1c
15%
Isotopes of Potassium
15%
Tricuspid Valve Regurgitation
10%
Cardiac Autonomic Neuropathy
10%
Obstruction
10%
Randomized Controlled Trial
9%
Cardiovascular Disease
9%
Captopril
9%
Hypercholesterolemia
7%
Atherosclerosis
7%
Myocardial Disease
6%
Survival Rate
6%
Cancer Chemotherapy
6%
Chemotherapy
6%
Adverse Event
5%
Observational Study
5%
Heart Outflow Tract Obstruction
5%
Heart Arrhythmia
5%
Hypokalemia
5%
Growth Disorder
5%